(Q40901652)

24 September 2017

1 reference

title

Chronic administration of etoposide in the treatment of non-Hodgkin's lymphoma (English)

1 reference

24 September 2017

1 reference

Hainsworth JD

1

1 reference

24 September 2017

publication date

1 January 1993

1 reference

24 September 2017

1 reference

24 September 2017

volume

10 Suppl

1 reference

24 September 2017

page(s)

65-72

1 reference

Activity of the epipodophyllotoxin VP-16 in the treatment of combination chemotherapy-resistant non-Hodgkin lymphoma

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F10428199309149115

Two epipodophyllotoxin derivatives, VM 26 and VP 16213, in the treatment of leukemias, hematosarcomas, and lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309149115

Review of etoposide single-agent activity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309149115

High-dose combination chemotherapy with autologous bone marrow transplantation in adult solid tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309149115

Proliferation dependence of topoisomerase II mediated drug action

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309149115

Chronic daily administration of oral etoposide in refractory lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309149115

10.3109/10428199309149115

21 January 2018

Identifiers

DOI

1 reference

24 September 2017

1 reference